Tarek A Hammad
Overview
Explore the profile of Tarek A Hammad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammad T, Davies S
Drug Saf
. 2025 Mar;
PMID: 40075033
Decision making in drug safety is a complex and iterative process that requires the integration of diverse evidence sources, scientific reasoning, and clinical judgment. Diverging opinions among stakeholders-including pharmacovigilance professionals,...
2.
Aimer O, Salas M, Hammad T, Mouchantaf R, Ilic K, Gossell-Williams M, et al.
Drug Saf
. 2024 Dec;
48(3):305-309.
PMID: 39692839
No abstract available.
3.
Youssef A, Blanchard N, Hammad T
Clin Ther
. 2024 Apr;
46(5):424-428.
PMID: 38677979
Pharmaceutical development is a highly regulated industry through numerous worldwide guidance, laws, and regulations. Issues related to the safety of pharmaceutical products have been the most common cause of withdrawals...
4.
Shishehbor M, Hammad T
JACC Cardiovasc Interv
. 2024 Mar;
17(5):619-621.
PMID: 38479963
No abstract available.
5.
Janssens R, Barbier L, Muller M, Cleemput I, Stoeckert I, Whichello C, et al.
Front Pharmacol
. 2023 Sep;
14:1192770.
PMID: 37663265
Patients have unique insights and are (in-)directly affected by each decision taken throughout the life cycle of medicinal products. Patient preference studies (PPS) assess what matters most to patients, how...
6.
Li J, Arora S, Wheat H, Dash S, Kimura S, Smith J, et al.
Vasc Med
. 2023 May;
28(5):387-396.
PMID: 37249001
Background: Inflammation and immune dysregulation have been associated with adverse outcomes in cardiovascular disease. There is limited understanding of the association of different profiles of white blood cell (WBC) subsets...
7.
Shishehbor M, Hammad T, Rhone T, Younes A, Kumins N, Abdullah A, et al.
Circ Cardiovasc Interv
. 2021 Dec;
15(1):e011306.
PMID: 34930016
No abstract available.
8.
Hammad T, Abu-Omar Y, Shishehbor M
Catheter Cardiovasc Interv
. 2021 Nov;
99(2):508-511.
PMID: 34766706
With the ongoing intravenous drug abuse (IVDA) epidemic, the number of IVDA patients with infective endocarditis is increasing. These cases are often characterized by large vegetations complicated by valvular dysfunction,...
9.
Li J, Arora S, Ikeoka K, Smith J, Dash S, Kimura S, et al.
Catheter Cardiovasc Interv
. 2021 Sep;
99(1):121-133.
PMID: 34541783
Objectives: To assess geriatric nutritional risk index (GNRI) in patients with chronic limb-threatening ischemia (CLTI). Background: The prevalence of CLTI continues to rise, with major amputation and mortality remaining prominent....
10.
Parikh M, Chahine N, Hammad T, Tefera L, Li J, Carman T, et al.
Catheter Cardiovasc Interv
. 2021 Apr;
97(7):1430-1437.
PMID: 33844438
Objectives: We sought to examine predictors of pulmonary embolism response team (PERT) utilization and identify those who could benefit from advanced therapy. Background: PERT and advanced therapy use remain low....